Given the essential role of TRIM9 in modulating HNRNPU stability and tumor progression, targeting TRIM9-mediated ubiquitination could provide a more specific approach to modulate protein degradation pathways in pancreatic cancer. This evidence concerns the gene TRIM9 and familial pancreatic carcinoma.